Retrospective analysis of 67 consecutive cases of pure XXXX .

@entity1 @entity43 @entity5 @entity787 @entity160 @entity7297 @entity44
OBJECTIVE: To investigate the development regularity, treatment methods and @entity44 ( @entity44 ). METHODS: Sixty-seven @entity1 with @entity44 , admitted from 1958 to 1998, were retrospectively analyzed. There were 31 @entity1 with stage I, 4 with stage II, 2 with stage III and 1 with stage IV lesions. Twenty-seven @entity1 had recurrences and 2 had distant metastases. Unilateral adnexectomy was performed for stage I lesions. From the 1980s, this was followed by four-cycles of combination chemotherapy (VAC, @entity7297 or BEP x 3 cycles) as post-operative adjuvant therapy. Combined chemotherapy and multiple operations were performed for advanced and recurrent lesions. RESULTS: The overall survival rate was 75% (50/67). However, there was a remarkable difference in the results from the various periods. From 1958 to 1983, the 5-year survival rate was 40% (6/15), and it was raised to 79% (26/33) from 1984 to 1993. In the period 1994 to 1998, 95% (18/19)of @entity1 were rescued. Thirty-five @entity1 who had early lesions (stage I and II) had a 5-year survival rate of 91.4% (32/35). Thirty-two @entity1 with recurrent or advanced lesions had a 5-years survival rate of 56% (18/32). There were 8 @entity1 with @entity5 and their 5-year survival rate was only 25% (2/8). The chief prognostic factors for this disease are clinical stage, pathological grade and adequate treatment. CONCLUSION: @entity44 is a potentially curable disease in today's practice. It is characterized by the fact that recurrent @entity5 may be converted back to mature ones as time goes on. With chemotherapy, these is a good opportunity to rescue those @entity1 with recurrent @entity5 . At present, treatment of @entity44 gives the most satisfactory results among all @entity43 types. Tests of serum specific @entity5 markers (CA19-9, @entity160 , CA125, @entity787 ) performed preoperatively or before chemotherapy and during follow-up have been found helpful in the evaluation of prognosis.
